NCT03667131View on ClinicalTrials.gov

Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis.

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

February 13, 2017

Primary Completion Date

December 8, 2017

Study Completion Date

February 19, 2018

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Enalapril Maleate

Enalapril Maleate 5 mg tablet, every 12 hrs for 90 days.

DRUG

Placebo

Placebo 5 mg tablet, every 12 hrs for 90 days.

Trial Locations (1)

44340

Instituto de Investigación en Reumatología y Sistema Músculo Esquelético, Guadalajara

All Listed Sponsors
lead

University of Guadalajara

OTHER

NCT03667131 - Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis. | Biotech Hunter | Biotech Hunter